Biomarkers · 2012 · 25 citations · 24 references
Life SciencesBiomedical SciencesToxicologyNanobiotechnologyNanomaterialsNeurodegenerationAlzheimer DiseaseCell-nanoparticle InteractionsMicrorna BiologyNanomedicineNanotoxicologyBiomarkersBlood-based BiomarkersCirculating Microrna DetectionCirculating MicrornasMicroarray AnalysisMicrorna BiomarkersNanoparticles
CONTEXT: Increased use of engineered nanoparticles may result in exposure of workers and consumers, making them a health concern. OBJECTIVE: To identify potential blood miRNA biomarkers after intravenous gold nanoparticle (AuNP) exposure. MATERIALS AND METHODS: miRNA microarray analysis was carried out on blood of rats at 1 week and 2 months after injection. RESULTS: Many up- and downregulated miRNAs were detected. Of these, rno-miR-298 was confirmed to be increased at 1 week postinjection by reverse transcription-PCR (RT-PCR). DISCUSSION AND CONCLUSION: Blood miRNAs could be useful as biomarkers for exposure to nanoparticles. miR-298 regulates β-amyloid (Aβ) precursor protein-converting enzyme-1 (BACE1) in Alzheimer's disease.
24
Xi Chen, Yi Ba, Lijia Ma et al. · Cell Research · 2008 · 4.6K citations
miRBase: tools for microRNA genomics
Sam Griffiths‐Jones, Harpreet K. Saini, Stijn van Dongen et al. · Nucleic Acids Research · 2007 · 4.4K citations · Full text